Results 91 to 100 of about 9,034 (208)
Background Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three clinically distinct forms: congenital, acquired and secondary.
Baritussio Aldo +7 more
doaj +1 more source
Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis [PDF]
Change from baseline in swollen (a) and tender (b) joint counts. *Error bars show upper SE for placebo and lower SE for namilumab. SE standard error, SJC swollen joint count, TJC tender joint count.
A. Batalov +47 more
core +3 more sources
Pulmonary alveolar proteinosis after lung transplantation
We report the case of a 69‐year‐old man five‐month post double lung transplant for idiopathic pulmonary fibrosis (IPF) who presented with progressive breathlessness, loss of lung function, and diffuse ground glass shadowing on the chest computed ...
Chandima Divithotawela +4 more
doaj +1 more source
Synovial tissue macrophages: friend or foe? [PDF]
Healthy synovial tissue includes a lining layer of synovial fibroblasts and macrophages. The influx of leucocytes during active rheumatoid arthritis (RA) includes monocytes that differentiate locally into proinflammatory macrophages, and these produce ...
Alivernini, Stefano +1 more
core +2 more sources
Venoarterial extracorporeal membrane oxygenation (ECMO) for support during whole lung lavage for pulmonary alveolar proteinosis. [PDF]
INTRODUCTION ECMO as support during whole lung lavage (WLL) for pulmonary alveolar proteinosis is reserved for severe cases where oxygenation is inadequate to support the patient using the ventilator alone.
Cavarocchi, Nicholas C +4 more
core +2 more sources
Background: Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by deposition of lipoproteinaceous material within alveoli, with a variable clinical course. Here, we report an experience of management of PAP at our center.
Vijay Hadda +12 more
doaj +1 more source
Therapy options in pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis is a rare condition characterized by the accumulation of lipoproteinaceous material within the airspaces, resulting in impaired gas transfer, and clinical manifestations ranging from asymptomatic to severe respiratory ...
Maurizio Luisetti +5 more
doaj +1 more source
Gravidez de termo em doente com proteinose alveolar e insuficiência respiratória grave
Resumo: A proteinose alveolar pulmonar (PAP) é uma doença rara caracterizada pela acumulação anormal de material lipoproteináceo nos alvéolos, que pode levar a insuficiência respiratória, estando associada a um risco elevado de infecções.
I. Belchior +5 more
doaj +1 more source
Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
Pulmonary alveolar proteinosis (PAP) is a progressive lung disease characterized by accumulated surfactant-like lipoproteinaceous material in the alveoli and distal bronchioles.
Sofya Tokman +6 more
doaj +1 more source
Case study: Patient with alveolar proteinosis
Alveolar proteinosis is a rare disease of unknown etiology in which the alveoli are filled with lipid-proteinaceous material. The diagnosis is usually made on an open lung biopsy.
S. P. Wessels
doaj +1 more source

